<div id="readability-page-1"><p><span>Madison Square Garden (NYSE:MSGS - Get Free Report)</span>'s stock had its &#34;peer perform&#34; rating reiterated by equities research analysts at Wolfe Research in a research report issued on Monday,Benzinga reports.</p><ul><li>Body Slammed Under $100, Is World Wrestling Stock an Opportunity?</li></ul><p>MSGS has been the topic of several other reports. BTIG Research started coverage on shares of Madison Square Garden in a research note on Tuesday, October 7th. They set a &#34;neutral&#34; rating on the stock. Zacks Research upgraded shares of Madison Square Garden from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Monday, October 13th. Citigroup initiated coverage on shares of Madison Square Garden in a report on Tuesday, September 9th. They issued a &#34;buy&#34; rating and a $285.00 target price on the stock. JPMorgan Chase &amp; Co. boosted their target price on shares of Madison Square Garden from $230.00 to $240.00 and gave the company an &#34;overweight&#34; rating in a research note on Monday, November 3rd. Finally, Weiss Ratings  reissued a &#34;sell (d+)&#34; rating on shares of Madison Square Garden in a report on Monday, December 8th. Five research analysts have rated the stock with a Buy rating, four have given a Hold rating and one  has assigned  a Sell rating to the stock. According to MarketBeat, Madison Square Garden presently has a consensus rating of &#34;Hold&#34; and a consensus target price of $260.50.</p><div><p><span></span><span>Get <strong>Madison Square Garden</strong> alerts:</span></p></div><p><b>Get Our Latest Stock Analysis on Madison Square Garden</b></p><h2>Madison Square Garden Trading Down 1.7%</h2><ul><li>MSG Sports: How To Buy the Knicks and Rangers for 50% Off</li></ul><p>Shares of MSGS stock traded down $4.06 during mid-day trading on Monday, reaching $233.38. The stock had a trading volume of 67,745 shares, compared to its average volume of 167,956. The firm has a market capitalization of $5.61 billion, a PE ratio of -238.77 and a beta of 0.66. The stock's 50-day moving average price is $222.01 and its two-hundred day moving average price is $209.96. Madison Square Garden has a 52-week low of $173.26 and a 52-week high of $243.71. </p><p>Madison Square Garden (NYSE:MSGS - Get Free Report) last issued its quarterly earnings data on Friday, October 31st. The company reported ($0.37) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.04) by $0.67. The business had revenue of $39.45 million for the quarter, compared to the consensus estimate of $41.41 million. Madison Square Garden had a negative net margin of 2.31% and a negative return on equity of 1.76%. The company's quarterly revenue was down 26.0% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.31) EPS.  On average, equities research analysts forecast that  Madison Square Garden will post 0.73 earnings per share for the current year. </p><h2>Institutional Inflows and Outflows</h2><p>A number of hedge funds and other institutional investors have recently modified their holdings of MSGS. Royal Bank of Canada raised its holdings in shares of  Madison Square Garden by 5.4% in the first quarter. Royal Bank of Canada now owns 54,949 shares of the company's stock valued at $10,701,000 after acquiring an additional 2,818 shares in the last quarter.  Invesco Ltd. lifted its position in shares of  Madison Square Garden by 16.7% during the first quarter. Invesco Ltd. now owns 97,121 shares of the company's stock valued at $18,911,000 after buying an additional 13,863 shares during the last quarter.  FORA Capital LLC bought a new stake in shares of  Madison Square Garden in the 1st quarter valued at about $272,000.  Goldman Sachs Group Inc. boosted its holdings in shares of  Madison Square Garden by 28.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 24,807 shares of the company's stock valued at $4,830,000 after buying an additional 5,452 shares in the last quarter.  Finally, T. Rowe Price Investment Management Inc. grew its position in shares of  Madison Square Garden by 6.0% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 528,545 shares of the company's stock worth $102,919,000 after buying an additional 29,938 shares during the last quarter. 68.94% of the stock is currently owned by institutional investors. </p><h2>Madison Square Garden Company Profile</h2> (Get Free Report)<p>Madison Square Garden Sports Corp. operates as a professional sports company in the United States. The company owns and operates a portfolio of assets that consists of the New York Knickerbockers of the National Basketball Association (NBA) and the New York Rangers of the National Hockey League. Its other professional franchises include development league teams, the Hartford Wolf Pack of the American Hockey League and the Westchester Knicks of the NBA G League.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Madison Square Garden</li><li>3 Natural Gas Stocks That Offer Great Dividend Yields</li><li>Super Micro's Sell-Off Is a Mirage—Here’s Why the Rally May Come Back Fast</li><li>How to Use the MarketBeat Excel Dividend Calculator</li><li>3 Companies Turning Big Cash Flow Into Bigger Shareholder Gains</li><li>5 discounted opportunities for dividend growth investors</li><li>GOOGL's Unstoppable Momentum Drives Price Targets to Record Highs</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1TR1M?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1TR1M"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Madison Square Garden Right Now?</h2><p>Before you consider Madison Square Garden, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Madison Square Garden wasn't on the list.</p><p>While Madison Square Garden currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

MSGS

<p>Wolfe Research reiterated a "peer perform" rating for Madison Square Garden (NYSE:MSGS). Other analysts have mixed ratings, with some issuing "buy" and "hold" ratings, and one "sell" rating. The stock's consensus rating is "Hold" with a target price of $260.50. Recent trading saw MSGS stock down 1.7% at $233.38. Institutional investors have been adjusting their holdings, with significant activity from Royal Bank of Canada, Invesco Ltd., and others.</p>

Wolfe Research Reiterates Peer Perform Rating for Madison Square Garden (NYSE:MSGS)